Keywords: بیسموت 213; Targeted α-therapy; Bismuth-213; Actinium-225; Radiolabeling; Radio-thin-layer chromatography; Macrocycles
مقالات ISI بیسموت 213 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
The Performance of two silica based ion exchange resins in the separation of 213Bi from its parent solution of 225Ac
Keywords: بیسموت 213; Separation; Bismuth-213; Actinium-225; Targeted radioimmunotherapy;
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
Keywords: بیسموت 213; Radioimmunotherapy; Alpha particle; Bismuth-213; Oncology: multiple myeloma; CD138; Melphalan;
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor o
Keywords: بیسموت 213; Targeted alpha-therapy; Radioimmunotherapy; Alpha-emitter; Bismuth-213; Anti-CD33-antibody; Acute myeloid leukaemia; Cancer; Radioresistance; Chemoresistance;
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters
Keywords: بیسموت 213; Radioimmunotherapy; Bismuth-213; Ovarian cancer cell line; MUC1; uPA; HER2
A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226
Keywords: بیسموت 213; Medical linear accelerator (linac); Actinium-225; Radium-226; Radium-225; Bismuth-213; Targeted alpha therapy; Cancer therapy
Production of actinium-225 for alpha particle mediated radioimmunotherapy
Keywords: بیسموت 213; Bismuth-213; Actinium-225; Radium-225; Thorium-229; Radiochemical processing; Ion exchange chromatography; Alpha-radioimmunotherapy; Myeloid leukemia;